{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T02:21:45Z","timestamp":1776824505407,"version":"3.51.2"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Center for Advanced Retinal and Ocular Therapeutics"},{"name":"The Brenda and Matthew Shapiro Stewardship"},{"name":"Robert and Susan Heidenberg Investigative Research Fund for Ocular Gene Therapy"},{"name":"The Pennsylvania Lions Sight Conservation and Research Foundation"},{"name":"The Paul and Evanina Bell Mackall Foundation Trust"},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.omtm.2019.08.011","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T19:23:50Z","timestamp":1567538630000},"page":"133-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Safety of Same-Eye Subretinal Sequential Readministration of AAV2-hRPE65v2 in Non-human Primates"],"prefix":"10.1016","volume":"15","author":[{"given":"Lindsey","family":"Weed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Ammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangzhen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangyong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leona W.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert M.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas S.","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2019.08.011_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-syndromic retinitis pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtm.2019.08.011_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrg2717","article-title":"Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait","volume":"11","author":"Wright","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtm.2019.08.011_bib3","series-title":"Leber Congenital Amaurosis","author":"Weleber","year":"2013"},{"key":"10.1016\/j.omtm.2019.08.011_bib4","doi-asserted-by":"crossref","first-page":"13658","DOI":"10.1073\/pnas.0504167102","article-title":"Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle","volume":"102","author":"Redmond","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2019.08.011_bib5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0076-6879(00)16758-8","article-title":"Genetic analysis of RPE65: from human disease to mouse model","volume":"316","author":"Redmond","year":"2000","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.omtm.2019.08.011_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/3813","article-title":"Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle","volume":"20","author":"Redmond","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2019.08.011_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/ng1097-139","article-title":"Mutations in RPE65 cause Leber\u2019s congenital amaurosis","volume":"17","author":"Marlhens","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2019.08.011_bib8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ng1097-194","article-title":"Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy","volume":"17","author":"Gu","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2019.08.011_bib9","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.preteyeres.2010.04.002","article-title":"Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy","volume":"29","author":"Cideciyan","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtm.2019.08.011_bib10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/sj.mt.6300389","article-title":"Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer","volume":"16","author":"Bennicelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.08.011_bib11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2019.08.011_bib12","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2019.08.011_bib13","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1073\/pnas.96.17.9920","article-title":"Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina","volume":"96","author":"Bennett","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2019.08.011_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-term effect of gene therapy on Leber\u2019s congenital amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2019.08.011_bib15","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1412965","article-title":"Improvement and decline in vision with gene therapy in childhood blindness","volume":"372","author":"Jacobson","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2019.08.011_bib16","first-page":"S592","article-title":"High levels of transgene expression after readministration of adeno-associated virus to the subretinal space","volume":"40","author":"Anand","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2019.08.011_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/mthe.2002.0525","article-title":"A deviant immune response to viral proteins and transgene product is generated on subretinal administration of adenovirus and adewno-associated virus","volume":"5","author":"Anand","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.08.011_bib18","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ymthe.2006.03.005","article-title":"Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection","volume":"13","author":"Jacobson","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.08.011_bib19","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1089\/hum.1996.7.14-1763","article-title":"Humoral response after administration of E1-deleted adenoviruses: immune privilege of the subretinal space","volume":"7","author":"Bennett","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.08.011_bib20","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.gt.3302030","article-title":"Immune response following intraocular delivery of recombinant viral vectors","volume":"10","author":"Bennett","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2019.08.011_bib21","first-page":"S117","article-title":"Induction of immune deviant response in the subretinal space is dependent on the nature of antigen introduced","volume":"41","author":"Anand","year":"2000","journal-title":"IOVS"},{"key":"10.1016\/j.omtm.2019.08.011_bib22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(16)30371-3","article-title":"Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial","volume":"388","author":"Bennett","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2019.08.011_bib23","doi-asserted-by":"crossref","first-page":"120ra15","DOI":"10.1126\/scitranslmed.3002865","article-title":"AAV2 gene therapy readministration in three adults with congenital blindness","volume":"4","author":"Bennett","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2019.08.011_bib24","first-page":"21ra16","article-title":"Safety and efficacy of subretinal re-administration of an AAV2 vector in large animal models: Implications for studies in humans","volume":"2","author":"Amado","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2019.08.011_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/gt.2010.111","article-title":"Gene therapy in the second eye of RPE65-deficient dogs improves retinal function","volume":"18","author":"Annear","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2019.08.011_bib26","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","article-title":"Immune responses to adenovirus and adeno-associated virus in humans","volume":"6","author":"Chirmule","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2019.08.011_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/humc.2016.048","article-title":"AAV Natural Infection Induces Broad Cross-Neutralizing Antibody Responses to Multiple AAV Serotypes in Chimpanzees","volume":"27","author":"Calcedo","year":"2016","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.omtm.2019.08.011_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1126\/science.3576186","article-title":"Distribution of cones in human and monkey retina: individual variability and radial asymmetry","volume":"236","author":"Curcio","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.omtm.2019.08.011_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1096-9861(19970203)378:1<117::AID-CNE7>3.0.CO;2-7","article-title":"Spatial and temporal expression of cone opsins during monkey retinal development","volume":"378","author":"Bumsted","year":"1997","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.omtm.2019.08.011_bib30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/(SICI)1096-9861(19990125)403:4<502::AID-CNE6>3.0.CO;2-N","article-title":"Distribution and development of short-wavelength cones differ between Macaca monkey and human fovea","volume":"403","author":"Bumsted","year":"1999","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.omtm.2019.08.011_bib31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/hum.2006.17.845","article-title":"Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis","volume":"17","author":"Jacobson","year":"2006","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.08.011_bib32","doi-asserted-by":"crossref","first-page":"e1001249","DOI":"10.1371\/journal.pgen.1001249","article-title":"Functional comparison of innate immune signaling pathways in primates","volume":"6","author":"Barreiro","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtm.2019.08.011_bib33","article-title":"A comprehensive atlas of immunological differences between humans, mice and non-human primates","author":"Bjornson-Hooper","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtm.2019.08.011_bib34","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/eye.1995.192","article-title":"Lipofuscin of the retinal pigment epithelium: a review","volume":"9","author":"Kennedy","year":"1995","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.omtm.2019.08.011_bib35","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1167\/iovs.13-12445","article-title":"Quantitative fundus autofluorescence in healthy eyes","volume":"54","author":"Greenberg","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2019.08.011_bib36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.abb.2004.05.016","article-title":"Autofluorescence method to measure macular pigment optical densities fluorometry and autofluorescence imaging","volume":"430","author":"Delori","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.omtm.2019.08.011_bib37","first-page":"AAV8","volume":"RGX-314","author":"Aleman","year":"2017","journal-title":"Safety of"},{"key":"10.1016\/j.omtm.2019.08.011_bib38","first-page":"3023","article-title":"Effect of Rpe65 knockout on accumulation of lipofuscin fluorophores in the retinal pigment epithelium","volume":"42","author":"Katz","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2019.08.011_bib39","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.ophtha.2004.01.033","article-title":"Lack of fundus autofluorescence to 488 nanometers from childhood on in patients with early-onset severe retinal dystrophy associated with mutations in RPE65","volume":"111","author":"Lorenz","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtm.2019.08.011_bib40","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1167\/iovs.07-1671","article-title":"A comprehensive clinical and biochemical functional study of a novel RPE65 hypomorphic mutation","volume":"49","author":"Lorenz","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2019.08.011_bib41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2018-07-820720","article-title":"Update on clinical gene therapy for hemophilia","volume":"133","author":"Perrin","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2019.08.011_bib42","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/mt.2008.284","article-title":"Striatal readministration of rAAV vectors reveals an immune response against AAV2 capsids that can be circumvented","volume":"17","author":"Peden","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.08.011_bib43","doi-asserted-by":"crossref","first-page":"e0209996","DOI":"10.1371\/journal.pone.0209996","article-title":"The influence of subretinal injection pressure on the microstructure of the monkey retina","volume":"13","author":"Takahashi","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2019.08.011_bib44","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1167\/iovs.07-0453","article-title":"Inner retinal abnormalities in X-linked retinitis pigmentosa with RPGR mutations","volume":"48","author":"Aleman","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2019.08.011_bib45","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/IAE.0000000000002027","article-title":"Frequent subclinical macular changes in combined BRAF\/MEKinhibition with high-dose hydroxychloroquine as treatment for advanced BRAF mutant melanoma: Preliminary results from a phase I\/II clinical treatment trial","volume":"39","author":"Nti","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.omtm.2019.08.011_bib46","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3928\/23258160-20161031-06","article-title":"Fundus Autofluorescence Patterns of Submacular Fluid Resolution Following Repair of Macula-Involving Rhegmatogenous Retinal Detachments","volume":"47","author":"Simonett","year":"2016","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"10.1016\/j.omtm.2019.08.011_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archophthalmol.2011.295","article-title":"Functional and anatomic consequences of subretinal dosing in the cynomolgus macaque","volume":"130","author":"Nork","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.omtm.2019.08.011_bib48","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1016\/j.ymthe.2017.08.018","article-title":"AAV8 Can Induce Innate and Adaptive Immune Response in the Primate Eye","volume":"25","author":"Reichel","year":"2017","journal-title":"Mol Ther."},{"key":"10.1016\/j.omtm.2019.08.011_bib49","article-title":"Safety and toxicology of ocular gene therapy with recombinant AAV Vector rAAV.hCNGA3 in non-human primates","author":"Peters","year":"2019","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.omtm.2019.08.011_bib50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00006982-199414020-00014","article-title":"Retinal adhesiveness in surgically enucleated human eyes","volume":"14","author":"Marmor","year":"1994","journal-title":"Retina"},{"key":"10.1016\/j.omtm.2019.08.011_bib51","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1167\/iovs.06-0491","article-title":"Ultrastructural changes after artificial retinal detachment with modified retinal adhesion","volume":"47","author":"Szurman","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2019.08.011_bib52","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/eye.2017.158","article-title":"Technique of retinal gene therapy: delivery of viral vector into the subretinal space","volume":"31","author":"Xue","year":"2017","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.omtm.2019.08.011_bib53","doi-asserted-by":"crossref","first-page":"e104145","DOI":"10.1371\/journal.pone.0104145","article-title":"An arched micro-injector (ARCMI) for innocuous subretinal injection","volume":"9","author":"You","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2019.08.011_bib54","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1089\/hgtb.2016.086","article-title":"Evaluation of an Optimized Injection System for Retinal Gene Therapy in Human Patients","volume":"27","author":"Fischer","year":"2016","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2019.08.011_bib55","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1167\/iovs.17-22402","article-title":"Subretinal Injection for Gene Therapy Does Not Cause Clinically Significant Outer Nuclear Layer Thinning in Normal Primate Foveae","volume":"58","author":"Ochakovski","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2019.08.011_bib56","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1167\/iovs.17-22473","article-title":"Superior Retinal Gene Transfer and Biodistribution Profile of Subretinal Versus Intravitreal Delivery of AAV8 in Nonhuman Primates","volume":"58","author":"Seitz","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtm.2019.08.011_bib57","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0140-6736(15)00345-1","article-title":"Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial","volume":"386","author":"Rakoczy","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2019.08.011_bib58","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.visres.2007.01.025","article-title":"Normal ocular development in young rhesus monkeys (Macaca mulatta)","volume":"47","author":"Qiao-Grider","year":"2007","journal-title":"Vision Res."},{"key":"10.1016\/j.omtm.2019.08.011_bib59","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(09)61836-5","article-title":"Age-dependent effects of RPE65 gene therapy for Leber\u2019s congenital amaurosis: a phase 1 dose-escalation trial","volume":"374","author":"Maguire","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2019.08.011_bib60","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1167\/iovs.18-24708","article-title":"RDH12 Mutations Cause a Severe Retinal Degeneration With Relatively Spared Rod Function","volume":"59","author":"Aleman","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Molecular Therapy - Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119300919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119300919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:21:57Z","timestamp":1762420917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050119300919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":60,"alternative-id":["S2329050119300919"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2019.08.011","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of Same-Eye Subretinal Sequential Readministration of AAV2-hRPE65v2 in Non-human Primates","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2019.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors.","name":"copyright","label":"Copyright"}]}}